At BBCH, we identify promising device, diagnostic, or drug technologies that target an unmet healthcare need, and develop them to exit through our deep & broad operational expertise.
Our aim is to bridge the gap between the lab and the market. Breakthrough, fascinating, and much-needed technologies are developed in universities and research institutions, and we help with the struggle of bringing them to the real world.
Science commercialization is our speciality. We support your bioscience projects with market studies & sizing, due diligence, strategy, business planning & execution, and more.
Our team includes highly expert and experienced healthcare & business professionals and entrepreneurs. We've assembled a broad team of dynamic analysts whose synergy will bring insights to your technology at any stage. Our CEO, Dr. Sam Bakri (MD, Harvard MBA), is a serial healthcare entrepreneur. He is the CEO of SolasCure Ltd. and Vice Chairman of Gelmetix Ltd. He was the CEO and co-founder of Kind Consumer, a UK based medical technology company, and the co-founder of AIDA Health (backed by Mayo Clinic).
We bring a fresh, unique, and insightful look into your ideas and make them happen. Our expertise mostly spans the US, Europe, and China.
For further information, contact us at info@bbch.com.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Solidere, Downtown, Beirut,lebanon
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Commercialization, Market entry, Biotechnology, Drugs, Devices, Diagnostics, Business plan, Strategy plan, Business plan execution, Tech transfer, Due diligence, Fundraising.
- HQ
- Beirut
Bbch Questions
Bbch's LinkedIn profile is https://lb.linkedin.com/company/bbchbeirut
Bbch has
7 employees.
View email and phone details for 7
employees at Bbch.
Bbch's industry is
Biotechnology Research
Bbch's categories are Biotechnology Research
Bbch's founding year is 2020
